List of Tables
    Table 1. Oral Antidiabetic Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Oral Antidiabetic Drugs Market Trends
    Table 3. Oral Antidiabetic Drugs Market Drivers
    Table 4. Oral Antidiabetic Drugs Market Challenges
    Table 5. Oral Antidiabetic Drugs Market Restraints
    Table 6. Global Oral Antidiabetic Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Oral Antidiabetic Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Oral Antidiabetic Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Oral Antidiabetic Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Oral Antidiabetic Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Oral Antidiabetic Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Oral Antidiabetic Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Oral Antidiabetic Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Oral Antidiabetic Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Oral Antidiabetic Drugs Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Oral Antidiabetic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Oral Antidiabetic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Drugs as of 2021)
    Table 18. Top Players of Oral Antidiabetic Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Oral Antidiabetic Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Oral Antidiabetic Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Oral Antidiabetic Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Oral Antidiabetic Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Oral Antidiabetic Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Oral Antidiabetic Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Oral Antidiabetic Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Oral Antidiabetic Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Oral Antidiabetic Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Oral Antidiabetic Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Oral Antidiabetic Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Oral Antidiabetic Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Oral Antidiabetic Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Oral Antidiabetic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Oral Antidiabetic Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Oral Antidiabetic Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Oral Antidiabetic Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Oral Antidiabetic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Oral Antidiabetic Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Oral Antidiabetic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Oral Antidiabetic Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Oral Antidiabetic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Eli Lilly Corporation Information
    Table 43. Eli Lilly Description and Business Overview
    Table 44. Eli Lilly Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Eli Lilly Oral Antidiabetic Drugs Product
    Table 46. Eli Lilly Recent Development
    Table 47. Abbott Corporation Information
    Table 48. Abbott Description and Business Overview
    Table 49. Abbott Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Abbott Product
    Table 51. Abbott Recent Development
    Table 52. Biocon Corporation Information
    Table 53. Biocon Description and Business Overview
    Table 54. Biocon Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Biocon Product
    Table 56. Biocon Recent Development
    Table 57. Sanofi Corporation Information
    Table 58. Sanofi Description and Business Overview
    Table 59. Sanofi Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Sanofi Product
    Table 61. Sanofi Recent Development
    Table 62. Sunpharma Corporation Information
    Table 63. Sunpharma Description and Business Overview
    Table 64. Sunpharma Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Sunpharma Product
    Table 66. Sunpharma Recent Development
    Table 67. Novartis Corporation Information
    Table 68. Novartis Description and Business Overview
    Table 69. Novartis Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Novartis Product
    Table 71. Novartis Recent Development
    Table 72. Novo Nordisk Corporation Information
    Table 73. Novo Nordisk Description and Business Overview
    Table 74. Novo Nordisk Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Novo Nordisk Product
    Table 76. Novo Nordisk Recent Development
    Table 77. Merck Corporation Information
    Table 78. Merck Description and Business Overview
    Table 79. Merck Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Merck Product
    Table 81. Merck Recent Development
    Table 82. Pfizer Corporation Information
    Table 83. Pfizer Description and Business Overview
    Table 84. Pfizer Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Pfizer Product
    Table 86. Pfizer Recent Development
    Table 87. Huadong Medicine Co.,Ltd. Corporation Information
    Table 88. Huadong Medicine Co.,Ltd. Description and Business Overview
    Table 89. Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Huadong Medicine Co.,Ltd. Product
    Table 91. Huadong Medicine Co.,Ltd. Recent Development
    Table 92. Lepu Medical Corporation Information
    Table 93. Lepu Medical Description and Business Overview
    Table 94. Lepu Medical Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Lepu Medical Product
    Table 96. Lepu Medical Recent Development
    Table 97. Hengrui Medicine Corporation Information
    Table 98. Hengrui Medicine Description and Business Overview
    Table 99. Hengrui Medicine Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. Hengrui Medicine Product
    Table 101. Hengrui Medicine Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Oral Antidiabetic Drugs Customers List
    Table 105. Oral Antidiabetic Drugs Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oral Antidiabetic Drugs Product Picture
    Figure 2. Global Oral Antidiabetic Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Oral Antidiabetic Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Oral Antidiabetic Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Oral Antidiabetic Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Oral Antidiabetic Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Oral Antidiabetic Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Oral Antidiabetic Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Oral Antidiabetic Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Oral Antidiabetic Drugs Report Years Considered
    Figure 11. Product Picture of Sulfonylureas
    Figure 12. Product Picture of Meglitinides
    Figure 13. Product Picture of Alpha-glucosidase inhibitors
    Figure 14. Global Oral Antidiabetic Drugs Market Share by Type in 2022 & 2028
    Figure 15. Global Oral Antidiabetic Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Oral Antidiabetic Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Oral Antidiabetic Drugs Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Oral Antidiabetic Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Oral Antidiabetic Drugs Price by Type (2017-2028) & (US$/Unit)
    Figure 20. United States Oral Antidiabetic Drugs Market Share by Type in 2022 & 2028
    Figure 21. United States Oral Antidiabetic Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Oral Antidiabetic Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Oral Antidiabetic Drugs Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Oral Antidiabetic Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Oral Antidiabetic Drugs Price by Type (2017-2028) & (US$/Unit)
    Figure 26. Product Picture of Hospitals
    Figure 27. Product Picture of Clinics
    Figure 28. Product Picture of Others
    Figure 29. Global Oral Antidiabetic Drugs Market Share by Application in 2022 & 2028
    Figure 30. Global Oral Antidiabetic Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Oral Antidiabetic Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Oral Antidiabetic Drugs Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Oral Antidiabetic Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Oral Antidiabetic Drugs Price by Application (2017-2028) & (US$/Unit)
    Figure 35. United States Oral Antidiabetic Drugs Market Share by Application in 2022 & 2028
    Figure 36. United States Oral Antidiabetic Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Oral Antidiabetic Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Oral Antidiabetic Drugs Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Oral Antidiabetic Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Oral Antidiabetic Drugs Price by Application (2017-2028) & (US$/Unit)
    Figure 41. North America Oral Antidiabetic Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Oral Antidiabetic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. United States Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Oral Antidiabetic Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Oral Antidiabetic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Oral Antidiabetic Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Oral Antidiabetic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. China Taiwan Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Oral Antidiabetic Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Oral Antidiabetic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Oral Antidiabetic Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Oral Antidiabetic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. UAE Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Oral Antidiabetic Drugs Value Chain
    Figure 74. Oral Antidiabetic Drugs Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed